Avidity Biosciences Inc. (RNA)
NASDAQ: RNA
· Real-Time Price · USD
46.46
0.39 (0.85%)
At close: Aug 15, 2025, 3:59 PM
46.25
-0.45%
After-hours: Aug 15, 2025, 06:04 PM EDT
Avidity Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 10.73M | 8.93M | 10.9M | 10.12M | 10.6M | 10.87M | 9.56M | 10.14M | 9.8M | 9.66M | 9.22M | 8.31M | 7.99M | 8.42M | 9.33M | 9.62M | 9.2M | 8.13M |
Cost of Revenue | 1.52M | 1.4M | 2.04M | 2.65M | 1.09M | 1.66M | 2.1M | 1.87M | 3.12M | 41.65M | 40.88M | 40.71M | 65.14M | 48.06M | 68.42M | 81.83M | 66.46M | 52.73M |
Gross Profit | 9.91M | 8.24M | 9.57M | 8.17M | 9.51M | 9.21M | 7.46M | 8.27M | 6.68M | -31.99M | -31.66M | -32.4M | -57.15M | -39.64M | -59.1M | -72.22M | -57.26M | -44.6M |
Operating Income | -521.78M | -433.27M | -378.94M | -324.69M | -285.18M | -255.19M | -230.79M | -217.27M | -203.57M | -197.24M | -178.91M | -164.24M | -148.59M | -128.65M | -118.05M | -95.8M | -77.98M | -61.98M |
Interest Income | 67.16M | 64.63M | 56.88M | 44.76M | 33.07M | 26.89M | 23.97M | 20.34M | 15.4M | 10.24M | 4.97M | 2.26M | 933K | 338K | 104K | 67K | 77K | 79K |
Pretax Income | -455.74M | -369.22M | -322.3M | -280.49M | -252.45M | -228.68M | -212.22M | -202.25M | -193.49M | -192.15M | -174M | -162.06M | -147.74M | -128.4M | -118.01M | -95.75M | -77.91M | -62.11M |
Net Income | -455.74M | -369.22M | -322.3M | -280.49M | -252.45M | -228.68M | -207.02M | -194.29M | -184.2M | -182.87M | -169.69M | -160.5M | -147.5M | -128.17M | -118M | -95.75M | -77.91M | -62.11M |
Selling & General & Admin | 122.08M | 105.94M | 85.6M | 72.77M | 63.22M | 54.77M | 53.58M | 48.45M | 44.82M | 41.23M | 37.73M | 34.78M | 31.3M | 28.88M | 26.2M | 23.58M | 20.73M | 17.38M |
Research & Development | 410.44M | 336.25M | 303.59M | 260.79M | 231.3M | 210.03M | 190.97M | 183.76M | 173.36M | 170.48M | 150.4M | 137.76M | 125.28M | 108.19M | 101.18M | 81.83M | 66.46M | 52.73M |
Other Expenses | n/a | -687K | -687K | -687K | -1.99M | -1.46M | 3.74M | 3.74M | 5.03M | 5.19M | -39K | -30K | -29K | -29K | -7K | 2K | 13K | 15K |
Operating Expenses | 532.51M | 441.51M | 388.51M | 332.86M | 292.54M | 263.5M | 243.24M | 230.92M | 218.18M | 211.71M | 188.14M | 172.54M | 156.57M | 137.07M | 127.38M | 105.41M | 87.18M | 70.12M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 131K |
Selling & Marketing Expenses | n/a | n/a | -641K | -1.26M | -1.26M | -1.26M | -615K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 532.51M | 442.19M | 389.83M | 334.81M | 295.78M | 266.06M | 245.16M | 232.22M | 218.18M | 211.71M | 188.14M | 172.54M | 156.57M | 137.07M | 127.38M | 105.41M | 87.18M | 70.12M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -5.2M | -7.96M | -9.29M | -9.29M | -4.31M | -1.56M | -240K | -254K | -42K | -51K | -72K | -58K |
Shares Outstanding (Basic) | 129.62M | 129.23M | 128.5M | 123.38M | 106.93M | 87.21M | 76.05M | 74.1M | 71.39M | 70.43M | 57.3M | 53.07M | 49.93M | 48.22M | 23.61M | 43.05M | 37.58M | 37.52M |
Shares Outstanding (Diluted) | 129.62M | 129.23M | 128.5M | 123.38M | 106.93M | 87.21M | 76.05M | 74.1M | 71.39M | 70.43M | 57.3M | 53.07M | 49.93M | 48.25M | 23.61M | 43.27M | 37.58M | 37.52M |
EPS (Basic) | -3.56 | -3.01 | -2.9 | -2.89 | -2.95 | -2.95 | -2.83 | -2.87 | -2.96 | -3.22 | -3.26 | -4.06 | -3.94 | -3.72 | -3.65 | -2.45 | -2.08 | -2.61 |
EPS (Diluted) | -3.56 | -3.01 | -2.9 | -2.89 | -2.95 | -2.95 | -2.83 | -2.87 | -2.96 | -3.22 | -3.25 | -4.05 | -3.93 | -3.71 | -3.65 | -2.45 | -2.08 | -2.61 |
EBITDA | -519.55M | -430.35M | -376.16M | -322.04M | -282.67M | -252.84M | -233.5M | -217.46M | -203.96M | -197.83M | -174.77M | -163.01M | -147.56M | -127.8M | -117.4M | -95.23M | -77.47M | -61.62M |
EBIT | -507.96M | -433.27M | -378.94M | -324.69M | -285.18M | -255.19M | -235.6M | -219.33M | -205.63M | -199.29M | -176.16M | -164.23M | -148.58M | -128.65M | -118.04M | -95.78M | -77.94M | -62M |
Depreciation & Amortization | 3.05M | 2.92M | 2.78M | 2.65M | 2.51M | 3.08M | 3.52M | 3.29M | 3.12M | 2.16M | 1.4M | 1.22M | 1.02M | 869K | 663K | 570K | 471K | 398K |